Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

  • Filters activated: AIDS. Clear all to show 4634 items.
1.

CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4+ T-Cell-Dependent Control of Senescence.

Mossanen JC, Kohlhepp M, Wehr A, Krenkel O, Liepelt A, Roeth AA, Möckel D, Heymann F, Lammers T, Gassler N, Hermann J, Jankowski J, Neumann UP, Luedde T, Trautwein C, Tacke F.

Gastroenterology. 2019 May;156(6):1877-1889.e4. doi: 10.1053/j.gastro.2019.01.247. Epub 2019 Jan 30.

PMID:
30710528
2.

Melatonin modulates dysregulated circadian clocks in mice with diethylnitrosamine-induced hepatocellular carcinoma.

Sánchez DI, González-Fernández B, Crespo I, San-Miguel B, Álvarez M, González-Gallego J, Tuñón MJ.

J Pineal Res. 2018 Oct;65(3):e12506. doi: 10.1111/jpi.12506. Epub 2018 May 28.

PMID:
29770483
3.

Evaluation of cytotoxicity of a purified venom protein from Naja kaouthia (NKCT1) using gold nanoparticles for targeted delivery to cancer cell.

Bhowmik T, Saha PP, Sarkar A, Gomes A.

Chem Biol Interact. 2017 Jan 5;261:35-49. doi: 10.1016/j.cbi.2016.11.007. Epub 2016 Nov 9.

PMID:
27836789
4.

Next-generation proteasome inhibitor oprozomib synergizes with modulators of the unfolded protein response to suppress hepatocellular carcinoma.

Vandewynckel YP, Coucke C, Laukens D, Devisscher L, Paridaens A, Bogaerts E, Vandierendonck A, Raevens S, Verhelst X, Van Steenkiste C, Libbrecht L, Geerts A, Van Vlierberghe H.

Oncotarget. 2016 Jun 7;7(23):34988-5000. doi: 10.18632/oncotarget.9222.

5.

p53-p66(shc)/miR-21-Sod2 signaling is critical for the inhibitory effect of betulinic acid on hepatocellular carcinoma.

Yang J, Qiu B, Li X, Zhang H, Liu W.

Toxicol Lett. 2015 Nov 4;238(3):1-10. doi: 10.1016/j.toxlet.2015.07.016. Epub 2015 Jul 26.

PMID:
26222667
6.

Matrix metalloproteinase 10 contributes to hepatocarcinogenesis in a novel crosstalk with the stromal derived factor 1/C-X-C chemokine receptor 4 axis.

García-Irigoyen O, Latasa MU, Carotti S, Uriarte I, Elizalde M, Urtasun R, Vespasiani-Gentilucci U, Morini S, Benito P, Ladero JM, Rodriguez JA, Prieto J, Orbe J, Páramo JA, Fernández-Barrena MG, Berasain C, Avila MA.

Hepatology. 2015 Jul;62(1):166-78. doi: 10.1002/hep.27798. Epub 2015 Apr 22.

PMID:
25808184
7.

Low-dose splenic radiation inhibits liver tumor development of rats through functional changes in CD4+CD25+Treg cells.

Wang B, Li B, Dai Z, Ren S, Bai M, Wang Z, Li Z, Lin S, Wang Z, Huang N, Yang P, Liu M, Min W, Ma H.

Int J Biochem Cell Biol. 2014 Oct;55:98-108. doi: 10.1016/j.biocel.2014.08.014. Epub 2014 Aug 25.

PMID:
25168696
8.

Overactivation of the TGF-β pathway confers a mesenchymal-like phenotype and CXCR4-dependent migratory properties to liver tumor cells.

Bertran E, Crosas-Molist E, Sancho P, Caja L, Lopez-Luque J, Navarro E, Egea G, Lastra R, Serrano T, Ramos E, Fabregat I.

Hepatology. 2013 Dec;58(6):2032-44. doi: 10.1002/hep.26597. Epub 2013 Oct 11.

PMID:
23813475
9.

Immunomodulatory effect of Stichopus japonicus acid mucopolysaccharide on experimental hepatocellular carcinoma in rats.

Song Y, Jin SJ, Cui LH, Ji XJ, Yang FG.

Molecules. 2013 Jun 19;18(6):7179-93. doi: 10.3390/molecules18067179.

10.

Effect of paeonol on antioxidant and immune regulatory activity in hepatocellular carcinoma rats.

Chen B, Ning M, Yang G.

Molecules. 2012 Apr 20;17(4):4672-83. doi: 10.3390/molecules17044672.

11.

Differential biodistribution of oncolytic poxvirus administered systemically in an autochthonous model of hepatocellular carcinoma.

Baril P, Touchefeu Y, Cany J, Cherel Y, Thorne SH, Tran L, Conchon S, Vassaux G.

J Gene Med. 2011 Dec;13(12):692-701. doi: 10.1002/jgm.1624.

PMID:
22028274
12.

Azidothymidine treatment of hepatocellular carcinoma in rats: an in vivo study of telomerase inhibition.

Jeng KS, Sheen IS, Jeng WJ.

Hepatogastroenterology. 2011 Nov-Dec;58(112):2091-6. doi: 10.5754/hge11087.

PMID:
22024081
13.

CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells.

Monnier J, Boissan M, L'Helgoualc'h A, Lacombe ML, Turlin B, Zucman-Rossi J, Théret N, Piquet-Pellorce C, Samson M.

Eur J Cancer. 2012 Jan;48(1):138-48. doi: 10.1016/j.ejca.2011.06.044. Epub 2011 Jul 19.

PMID:
21778049
14.

Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription.

Wu MH, Ma WL, Hsu CL, Chen YL, Ou JH, Ryan CK, Hung YC, Yeh S, Chang C.

Sci Transl Med. 2010 May 19;2(32):32ra35. doi: 10.1126/scitranslmed.3001143.

15.

Hepatoprotective and anti-hepatocarcinogenic effects of glycyrrhizin and matrine.

Wan XY, Luo M, Li XD, He P.

Chem Biol Interact. 2009 Sep 14;181(1):15-9. doi: 10.1016/j.cbi.2009.04.013. Epub 2009 May 6.

PMID:
19426721
16.

Pre-bled-young-rats in genotoxicity testing: a model for peripheral blood micronucleus assay.

Vikram A, Tripathi DN, Pawar AA, Ramarao P, Jena GB.

Regul Toxicol Pharmacol. 2008 Nov;52(2):147-57. doi: 10.1016/j.yrtph.2008.07.005. Epub 2008 Aug 3.

PMID:
18721840
17.

Modifying effect of Siraitia grosvenori extract on piperonyl butoxide-promoted hepatocarcinogenesis in rats.

Yasuno H, Nishimura J, Dewa Y, Muguruma M, Takabatake M, Murata Y, Shibutani M, Mitsumori K.

J Toxicol Sci. 2008 May;33(2):197-207.

19.

Pronounced inhibitory effect of chlorcyclizine (CCZ) in experimental hepatocarcinoma.

Dastidar SG, Ganguly K, Mahapatra SK, Dutta NK, Mazumdar K, Chakrabarty AN, Motohashi N.

In Vivo. 2006 Jan-Feb;20(1):97-102.

Supplemental Content

Loading ...
Support Center